Effect of ranitidine on soluble interleukin 2 receptors and CD8 molecules in surgical patients

British Journal of Surgery

Volumn 81, Issue 12, 1994, Pages 1747-1751

  Nielsen, H J ^a   Mynster, T ^a   Jensen, S ^b   Hammer, J ^a   Nielsen, H ^c  

^a HVIDOVRE HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HISTAMINE H2 RECEPTOR ANTAGONIST; INTERLEUKIN 2 RECEPTOR; RANITIDINE;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ABDOMEN; ADMINISTRATION, ORAL; AGED; ANTIGENS, CD8; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; RANITIDINE; RECEPTORS, INTERLEUKIN-2; SURGICAL PROCEDURES, ELECTIVE; TIME FACTORS;

EID: 0028029517     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.1800811213     Document Type: Article

References (60)

1. Monocyte dysfunction in severe trauma: evidence for the role of C5a in deactivation
2. Lymphocyte macrophage interactions in the response to surgical infections
3. Production and release of C3 by cultured monocytes/macrophages isolated from burned, trauma, and septic patients
4. Acceleration of superoxide production from leukocytes in trauma patients
5. Macrophage function and surgery. A clinical review with special reference to phagocytosis
6. Preoperative cell‐mediated immunity and duration of antibiotic prophylaxis in relation to postoperative infectious complications. A controlled trial in biliary, gastroduodenal and colorectal surgery
7. Polymorphonuclear leukocyte activation. An early marker of the postsurgical sepsis response
8. Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery
9. 2) receptor binding in production of the lymphohokine, soluble immune response suppressor (SIRS)
10. Immunosuppressive effects of a trauma‐induced suppressor active peptide
11. Human nonspecific suppressive lymphokines
12. Impaired production of interleukin‐2 after surgery
13. Mechanisms of immunosuppression associated with severe non‐thermal traumatic injuries in man: production of interleukin‐1 and 2
14. Capitalising on the therapeutic potential of inter‐leukin 2
15. Soluble cytokine receptors: their role in immunoregulation
16. The soluble interleukin‐2 receptor as a marker for human neoplasia and immune status
17. A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interieukin 2 with low affinity
18. Expression and secretion of IL‐2 receptor in trauma patients
19. Soluble IL‐2 receptors as an agent of serum‐mediated suppression in human visceral leishmaniasis
20. T‐cell subsets and the recognition of MHC class
21. Soluble CD8 during T cell activation
22. Serum soluble CD8 molecule is a marker of CD8 T‐cell activation in HIV‐1 disease
23. Ranitidine for prevention of postoperative suppression of delayed hypersensitivity
24. Ranitidine prevents postoperative transfusion‐induced depression of delayed hypersensitivity
25. Ranitidine improves postoperative depression in natural killer cell activity and delayed hypersensitivity
26. Ranitidine improves delayed hypersensitivity in patients with sepsis
27. Ranitidine improves post‐operative suppression of antibody response to preoperative vaccination
28. Ranitidine improves postoperative monocyte and neutrophil function
29. Soluble interleukin‐2 receptors are released from activated human lymphoid cells
30. A monoclonal antibody 7G7/B6 binds to an epitope on the human interleukin‐2 (IL‐2) receptor that is distinct from that recognized by IL‐2 or anti‐Tac
31. Comparison of the effects of SAG‐M and whole‐blood transfusions on postoperative suppression of delayed hypersensitivity
32. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery
33. Need for immunologic stimulators during immunosuppression produced by major cancer surgery
34. Inadequate interleukin 2 production. A fundamental immunological deficiency in patients with major burns
35. Decreased interleukin‐2 production in patients with gastrointestinal cancer
36. Lowest dose interleukin‐2 immunotherapy
37. Structure–function relationships for the IL‐2 receptor system. IV. Analysis of the sequence and ligand‐binding properties of soluble Tac protein
38. The soluble interleukin‐2 receptor in haematological disorders
39. Soluble IL‐2 receptor in rheumatoid arthritis. Correlation with disease activity, IL‐1 and IL‐2 inhibition
40. Soluble IL‐2 receptor in AIDS. Correlation of its serum level with the classification of HIV‐induced diseases and its characterization
41. The released interleukin 2 receptor binds interieukin 2 efficiently
42. Interleukin‐2 regulates its own receptors
43. Immunochemical analysis of the released Leu‐2 (T8) molecule
44. Spontaneous release of the Leu‐2 (T8) molecule from human T cells
45. Increased serum CD8 antigen level in childhood Hodgkin's disease relates to advanced stage and poor treatment outcome
46. Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor‐risk patients
47. Enzyme immunoassay for the quantification of cell‐free human T‐celi CD8‐like molecule
48. Perioperative immunotherapy with recombinant interieukin 2 in patients undergoing surgery for colorectal cancer
49. The role of complement in inflammation and phagocytosis
50. Anaphylatoxm‐induced histamine release from human leukocytes. Studies of C3a leukocyte binding and histamine release
51. An assessment of plasma histamine concentrations during documented endotoxic shock
52. Histamine modulation of lymphocyte biology: membrane receptors, signal transduction, and function
53. Elevated plasma histamine concentration as a sensitive real time parameter for distinct phases of surgical trauma: a tool for technology assessment
54. Histamine inhibits interferon‐gamma production via suppression of interleukin 2 synthesis
55. Role of histamine in the chemotactic deactivation of polymorphonuclear leukocytes following incubation with formylmethionyl peptides
56. +) subpopulation distinct from that which gives rise to cytotoxic T cells
57. Histamine type‐2 receptor antagonist immune modulation. II. Cimetidine and ranitidine increase interleukin‐2 production
58. + T cells by interleukin‐2 and cimetidine
59. Possible role of histamine‐2 receptor antagonists as adjuvant treatment in colorectal cancer. Clinical review
60. 2‐receptor antagonists. Effects on myelo‐peroxidase‐catalysed reactions and hydroxyl radical generation in a ferrous‐hydrogen peroxide system